Aspergillus Antigen, EIA, Serum
Also known as: Invasive Aspergillosis, Platelia Aspergillus Antigen, Aspergillus Galactomannan
Use
This immunoassay detects circulating Aspergillus antigen (galactomannan) in serum to aid in the diagnosis of invasive aspergillosis in at-risk patients, such as immunocompromised individuals.
Special Instructions
Serum should be collected in a plastic serum separator tube (SST) and centrifuged to separate from clot; avoid contamination with mold during collection, processing, shipment.
Limitations
This assay has not been cleared or approved by FDA; it is a laboratory-developed test validated under CLIA regulations. It has not been evaluated for use with plasma, urine, or CSF; for BAL specimens, a separate test code is required.
Methodology
Immunoassay (Other)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
Plastic SST tube
Collection Instructions
Serum should be collected in a plastic SST tube and spun to separate from the clot. Care is required to avoid contamination of specimens with mold during collection, processing, and shipment.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 5 days |
| Frozen | 5 months at ≤ -70°C |